West Pharmaceutical Services Inc

مادة اعلانية

Latest Update: 16 May 2025 23:59 Abu Dhabi Time.

Market Status: Closed

WST

West Pharmaceutical Services Inc

216.60

USD

5.920

2.81%

Open

211.50

Prev Close

210.68

PX_VOLUME

MARKET CAP (M)

DAY RANGE

208.68 - 216.68

52 WEEKS

187.43 - 356.14

Stock Statistics

Yearly Change

-38.82%

Listed Shares (Million)

75.30

Earnings Multiple

33.11

Average 30-day trading volume

723,414.37

Price-to-book ratio

5.64

Earnings Per Share

6.75

Previous Dividend Distribution

0.83

Dividend Yield

0.39%

Financial Summary

Quarterly
Annual

Income Statements

	Period Ending:	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Revenue		698.00	748.80	746.90	702.10	695.40	732.00	747.40
Gross Profit		231.90	273.60	264.70	230.00	230.20	278.20	288.30
Operating Income		124.90	167.90	163.90	128.50	124.60	167.80	185.40
Net Income		86.40	128.10	132.10	106.80	111.00	133.70	157.60
Profit Margin		12.38	17.11	17.69	15.21	15.96	18.27	21.09

	Period Ending:	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Revenue		2,893.20	2,949.80	2,886.90	2,831.60	2,146.90
Gross Profit		998.50	1,129.20	1,136.20	1,177.70	767.80
Operating Income		589.50	709.40	754.90	757.20	417.70
Net Income		478.00	575.70	559.50	640.30	328.80
Profit Margin		16.52	19.52	19.38	22.61	15.32

Balance Sheet

	Period Ending:	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Assets		3,618.20	3,643.40	3,675.10	3,489.40	3,602.30	3,829.50	3,754.70
Total Liabilities		935.10	961.10	923.00	912.60	921.70	948.50	886.50
Total Equity		2,683.10	2,682.30	2,752.10	2,576.80	2,680.60	2,881.00	2,868.20

	Period Ending:	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Assets		3,643.40	3,829.50	3,616.80	3,313.80	2,793.80
Total Liabilities		961.10	948.50	931.90	978.40	939.30
Total Equity		2,682.30	2,881.00	2,684.90	2,335.40	1,854.50

Cash Flows Statements

	Period Ending:	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Cash From Operating Activities		129.40	190.10	180.10	165.00	118.20	239.10	230.10
Cash From Investing Activities		-71.30	-104.80	-82.10	-101.20	-90.60	-108.80	-95.70
Cash From Financing Activities		-147.00	-68.90	-64.40	-218.30	-271.00	-189.50	-22.30
Net Change in Cash		-80.40	-6.30	44.70	-155.60	-252.10	-44.70	102.30

	Period Ending:	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash From Operating Activities		653.40	776.50	724.00	584.00	472.50
Cash From Investing Activities		-378.70	-368.70	-288.20	-253.10	-179.50
Cash From Financing Activities		-622.60	-459.60	-293.60	-168.10	-137.10
Net Change in Cash		-369.30	-40.40	131.70	147.10	176.40

* In Million of United States Dollar

Reminder: The financial information on this website is delayed information that are originates from certified data providers in the financial markets, who retain the rights and intellectual property of this data, absolving ADMN of any responsibility.

WST

West Pharmaceutical Services Inc

ويست فارماسوتيكال سيرفيسز إنك